Declaration of competing interest statements were not included in the published version of the following articles that appeared in previous issues of Liver Research.
The appropriate declaration of competing Interest statements, provided by the authors, are included below.
1. “Immune cells in alcohol-related liver disease” [Liver Res. 6 (2022) 1–9] https://doi.org/10.1016/j.livres.2022.01.001
Declaration of competing interest: Hua Wang is an editorial board member for Liver Research and was not involved in the editorial review or the decision to publish this article. Both authors declare that there are no competing interests.
2. “Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021” [Liver Res. 6 (2022) 50–57] https://doi.org/10.1016/j.livres.2022.01.002
Declaration of competing interest: Wen-Xing Ding is an associate editor and Hua Wang is an editorial board member for Liver Research. They were not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
3. “Chinese expert consensus on evaluation of donor and donor liver for split liver transplantation” [Liver Res. 6 (2022) 59–65] https://doi.org/10.1016/j.livres.2022.03.002
Declaration of competing interest: Guihua Chen is an editor-in-chief, Yang Yang is an executive associate editor, and Ziqing Hei and Jin Wang are editorial board members for Liver Research. They were not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
4. “Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma” [Liver Res. 6 (2022) 66–71] https://doi.org/10.1016/j.livres.2022.04.001
Declaration of competing interest: Zhiliang Gao is an associate editor for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
5. “Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice” [Liver Res. 6 (2022) 84–92] https://doi.org/10.1016/j.livres.2022.05.001
Declaration of competing interest: Grace L. Guo is an editorial board member for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
6. “Camrelizumab (SHR-1210) treatment for recurrent hepatocellular carcinoma after liver transplant: A report of two cases” [Liver Res. 6 (2022) 111–115] https://doi.org/10.1016/j.livres.2021.06.002
Declaration of competing interest: Yang Yang is an executive associate editor and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
7. “Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure” [Liver Res. 6 (2022) 121–129] https://doi.org/10.1016/j.livres.2022.08.002
Declaration of competing interest: Guihua Chen is an editor-in-chief and Yang Yang is an executive associate editor for Liver Research. They were not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
8. “Wu Mengchao: A blade warrior against liver cancer” [Liver Res. 6 (2022) 130–131] https://doi.org/10.1016/j.livres.2021.11.002
Declaration of competing interest: Qi Zhang is an editorial board member for Liver Research and was not involved in the editorial review or the deision to publish this article. All authors declare that there are no competing interests.
9. “Telehealth interventions for alcohol use disorder: A systematic review” [Liver Res. 6 (2022) 146–154] https://doi.org/10.1016/j.livres.2022.08.004
Declaration of competing interest: Yulan Liang is an editorial board member for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
10. “Glycogen accumulation drives hepatocarcinogenesis by targeting the Hippo signaling pathway” [Liver Res. 6 (2022) 198–200] https://doi.org/10.1016/j.livres.2022.07.001
Declaration of competing interest: Qi Zhang is an editorial board member for Liver Research and was not involved in the editorial review or the decision to publish this article. Both authors declare that there are no competing interests.
11. “Pathogenesis of fatty liver diseases and hepatocellular carcinoma” [Liver Res. 6 (2022) 201–202] https://doi.org/10.1016/j.livres.2022.12.001
Declaration of competing interest: John Y. L. Chiang is an executive associate editor for Liver Research. John Y. L. Chiang and Tiangang Li were guest editors of the special issue “Recent advances in understanding the pathogenesis of alcoholic and non-alcoholic fatty liver diseases and hepatocellular carcinoma”. They were not involved in the editorial review or the decision to publish this article. Both authors declare that there are no competing interests.
12. “Altered serotonin metabolism in Takeda G protein-coupled receptor 5 knockout mice protects against diet-induced hepatic fibrosis” [Liver Res. 6 (2022) 214–226] https://doi.org/10.1016/j.livres.2022.11.009
Declaration of competing interest: John Y. L. Chiang is an executive associate editor for Liver Research and was a guest editor of the special issue “Recent advances in understanding the pathogenesis of alcoholic and non-alcoholic fatty liver diseases and hepatocellular carcinoma”. He was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
13. “Chemical basis of pregnane X receptor activators in the herbal supplement Gancao (licorice)” [Liver Res. 6 (2022) 251–257] https://doi.org/10.1016/j.livres.2022.11.007
Declaration of competing interest: Wen Xie is an editorial board member for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
14. “Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis” [Liver Res. 6 (2022) 276–283] https://doi.org/10.1016/j.livres.2022.11.002
Declaration of competing interest: Tiangang Li was a guest editor of the special issue “Recent advances in understanding the pathogenesis of alcoholic and non-alcoholic fatty liver diseases and hepatocellular carcinoma” and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
15. “A dual role of inflammation in acetaminophen-induced liver injury” [Liver Res. 7 (2023) 9–15] https://doi.org/10.1016/j.livres.2023.03.001
Hua Wang is an associate editor for Liver Research and was not involved in the editorial review or the decision to publish this article. Both authors declare that there are no competing interests.
16. “Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases” [Liver Res. 7 (2023) 116–123] https://doi.org/10.1016/j.livres.2023.05.001
Yu-Jui Yvonne Wan is an executive associate editor for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
17. “Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue” [Liver Res. 7 (2023) 136–144] https://doi.org/10.1016/j.livres.2023.04.002
Zhi-Liang Gao is an associate editor for Liver Research and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.